Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.7 million.

  • Biodesix's Non Operating Income rose 12.0% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 2328.57%. This contributed to the annual value of -$8.4 million for FY2024, which is 2194.56% up from last year.
  • As of Q3 2025, Biodesix's Non Operating Income stood at -$1.7 million, which was up 12.0% from -$1.7 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Non Operating Income registered a high of $1.6 million during Q3 2021, and its lowest value of -$6.4 million during Q4 2022.
  • Moreover, its 5-year median value for Non Operating Income was -$2.0 million (2025), whereas its average is -$2.2 million.
  • Per our database at Business Quant, Biodesix's Non Operating Income skyrocketed by 16053.74% in 2021 and then tumbled by 41509.2% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Non Operating Income stood at -$1.6 million in 2021, then crashed by 302.25% to -$6.4 million in 2022, then surged by 64.81% to -$2.3 million in 2023, then grew by 29.4% to -$1.6 million in 2024, then fell by 3.93% to -$1.7 million in 2025.
  • Its Non Operating Income was -$1.7 million in Q3 2025, compared to -$1.7 million in Q2 2025 and -$2.0 million in Q1 2025.